Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Ann Surg. 2012 Aug;256(2):274-9. doi: 10.1097/SLA.0b013e31825c13d5.
Extent of distal resection margins in rectal cancer surgery remains controversial. We set out to determine the long-term oncologic impact of resection margins in patients with locally advanced rectal cancer using a comprehensive pathologic whole-mount section analysis.
It has been demonstrated that there is minimal disease beyond the gross tumor margin after neoadjuvant combined modality therapy (CMT) for rectal cancer. Although this suggests that close resection margins may be used for sphincter preservation, the long-term oncologic impact of this approach is unclear.
We prospectively enrolled 103 patients with locally advanced rectal cancer after neoadjuvant CMT. Whole-mount pathologic analysis was performed, and clinicopathologic variables were correlated with disease-specific survival (DSS).
: Sphincter preservation was achieved in 80% of patients, and the median distal margin was 2 cm (0.1 to 10 cm). There were 22 patients (21%) with distal margins 1 cm or less and no patient had a positive distal margin. Median radial margin was 1 cm and 4 patients (4%) had a margin of 1 mm or less. Viable distal intramural tumor spread was found in 3 patients (2.7%) and in all cases was limited to 1 cm or less from the gross tumor edge. At a median follow-up of 68 months, 5-year DSS was 86% and 1 patient experienced a local recurrence. Factors predictive of worse DSS included advanced tumor (T) and nodal (N) stage, tumor progression on neoadjuvant CMT, lack of a complete pathologic response, tumor location of 5 cm or less from the anal verge, and neurovascular invasion. The extent of the distal and radial margins of resection was not associated with DSS.
These results suggest that carefully selected patients with locally advanced rectal cancers who undergo neoadjuvant CMT can achieve excellent local control and DSS with a sphincter-sparing rectal resection and a margin distal clearance of 1 cm.
直肠癌手术中远端切除边界的范围仍存在争议。我们旨在通过全面的病理全切片分析来确定局部晚期直肠癌患者切除边界的长期肿瘤学影响。
已经证明,在新辅助联合治疗(CMT)后,直肠癌的大体肿瘤边缘之外几乎没有疾病。尽管这表明可以为保留肛门括约肌而使用近距离切除边缘,但这种方法的长期肿瘤学影响尚不清楚。
我们前瞻性地招募了 103 例新辅助 CMT 后局部晚期直肠癌患者。进行了全切片病理分析,并将临床病理变量与疾病特异性生存率(DSS)相关联。
80%的患者实现了肛门括约肌保留,中位远端切缘为 2cm(0.1 至 10cm)。有 22 例(21%)患者的远端切缘为 1cm 或更短,没有患者的远端切缘阳性。中位径向切缘为 1cm,4 例(4%)患者的切缘为 1mm 或更短。在 3 例(2.7%)患者中发现了有活性的远端壁内肿瘤扩散,并且在所有情况下,肿瘤从大体肿瘤边缘扩散均限制在 1cm 或更短的范围内。在中位随访 68 个月时,5 年 DSS 为 86%,1 例患者出现局部复发。预测 DSS 较差的因素包括肿瘤进展期(T)和淋巴结(N)期、新辅助 CMT 时肿瘤进展、缺乏完全病理缓解、肿瘤位置距肛门边缘 5cm 或更短、以及神经血管侵犯。远端和径向切除边界的范围与 DSS 无关。
这些结果表明,在接受新辅助 CMT 的局部晚期直肠癌患者中,经过精心选择,可以通过保留肛门括约肌的直肠切除术和 1cm 的远端清除来实现出色的局部控制和 DSS。